Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 26;13(1):28.
doi: 10.3390/biomedicines13010028.

Association of Low-Attenuation Plaque with Impaired Glucose Tolerance and Type 2 Diabetes Mellitus in Patients with Suspected Coronary Artery Disease

Thomas R Andersen  1   2 , Katrine S Overgaard  1   2 , Laurits Juhl Heinsen  1   2 , Roda Abdulkadir Mohamed  1   2 , Helle Precht  1   3   4   5   6 , Jess Lambrechtsen  1   2 , Søren Auscher  1   2 , Kenneth Egstrup  1   2
Affiliations

Association of Low-Attenuation Plaque with Impaired Glucose Tolerance and Type 2 Diabetes Mellitus in Patients with Suspected Coronary Artery Disease

Thomas R Andersen et al. Biomedicines. .

Abstract

Aim: The aim of this study was to evaluate the differences in plaque composition and burden between normal glycemic status (NGS) and dysglycemia expressed as impaired glucose tolerance (IGT) and type 2 diabetes mellitus (T2DM).

Methods: Clinically indicated coronary computed tomography angiography was used to evaluate patients with suspected coronary artery disease (CAD). An oral glucose tolerance test was performed to assess glycemic status. Patients were stratified as NGS, IGT, and T2DM. Plaque volumes were quantified using validated software, with further compositional measurements of low-attenuation, non-calcified, and calcified plaque burden.

Results: Of 355 patients with suspected CAD, 220 had NGS, 92 were diagnosed with IGT, and 43 with known T2DM. Low-attenuation plaque volume was significantly higher in IGT (209 mm3, p < 0.02) and T2DM (243 mm3, p = 0.005) compared with NGS (166 mm3). Total plaque burden was similar between all groups, but a significantly greater low-attenuation plaque burden was seen in IGT (p = 0.03) and T2DM (p = 0.02) compared with NGS. The multivariate linear regression model adjusted for clinical risk factors showed that patients with IGT had a greater low-attenuation plaque burden compared with those with NGS (p = 0.03). Interestingly, no significant differences in plaque burdens were observed between those with IGT and T2DM in both univariate and multivariate analyses.

Conclusions: Dysglycemia, including impaired glucose tolerance and type 2 diabetes mellitus, was associated with increased low-attenuation plaque burden compared with normal glycemic status. Patients with IGT demonstrated plaque burden similar to patients with known T2DM, underscoring the need for early metabolic intervention.

Keywords: computed coronary tomography angiography; dysglycemia; impaired glucose tolerance; low-attenuation plaque; plaque burden; plaque composition; type 2 diabetes mellitus.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Consort diagram showing patient enrollment and exclusion.
Figure 2
Figure 2
WHO criteria for oral glucose tolerance test stratification.
Figure 3
Figure 3
Representative longitudinal and transverse images of coronary plaque quantification on left anterior descending artery.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Rooney M.R., Fang M., Ogurtsova K., Ozkan B., Echouffo-Tcheugui J.B., Boyko E.J., Magliano D.J., Selvin E. Global Prevalence of Prediabetes. Diabetes Care. 2023;46:1388–1394. doi: 10.2337/dc22-2376. - DOI - PMC - PubMed
    1. Richter B., Hemmingsen B., Metzendorf M.-I., Takwoingi Y. Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia. Cochrane Database Syst. Rev. 2018;2018:CD012661. doi: 10.1002/14651858.CD012661.pub2. - DOI - PMC - PubMed
    1. Cao Z., Li W., Wen C.P., Li S., Chen C., Jia Q., Li W., Zhang W., Tu H., Wu X. Risk of Death Associated with Reversion from Prediabetes to Normoglycemia and the Role of Modifiable Risk Factors. JAMA Netw. Open. 2023;6:e234989. doi: 10.1001/jamanetworkopen.2023.4989. - DOI - PMC - PubMed
    1. Pararajasingam G., Høfsten D.E., Løgstrup B.B., Egstrup M., Henriksen F.L., Hangaard J., Egstrup K. Newly detected abnormal glucose regulation and long-term prognosis after acute myocardial in-farction: Comparison of an oral glucose tolerance test and glycosylated haemoglobin A1c. Int. J. Cardiol. 2016;214:310–315. doi: 10.1016/j.ijcard.2016.03.199. - DOI - PubMed
    1. Huang Y., Cai X., Mai W., Li M., Hu Y. Association between prediabetes and risk of cardiovascular disease and all cause mortality: Systematic review and meta-analysis. BMJ. 2016;355:i5953. doi: 10.1136/bmj.i5953. - DOI - PMC - PubMed

LinkOut - more resources